William Telle
Urology · Hot Springs, ARNPI 1942267984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in AR, where the typical reported total is $5,249.
Across 81 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$270
- Astellas Pharma US Inc$220
- Pfizer$130
- Boston Scientific$101
- Axonics, Inc.$64
- Antares Pharma, Inc.$63
- plus $526 from 21 others
What the payments were for
- Food & beverage$1,34698%
- Education$282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $270 |
| Astellas Pharma US Inc | 16 | $220 |
| Pfizer | 8 | $130 |
| Boston Scientific | 5 | $101 |
| Axonics, Inc. | 3 | $64 |
| Antares Pharma, Inc. | 5 | $63 |
| Myriad Genetic Laboratories, Inc. | 3 | $51 |
| Blue Earth Diagnostics | 2 | $49 |
| Coloplast | 4 | $48 |
| Merck | 2 | $38 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $29 |
| Myovant Sciences Inc. | 2 | $29 |
| Accord Healthcare, Inc. | 2 | $27 |
| Urovant Sciences Inc | 2 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Duchesnay USA Incorporated | 1 | $21 |
| Sanofi | 1 | $20 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
| Medtronic | 1 | $18 |
| Bayer | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Urogen Pharma, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Neotract Inc. | 1 | $13 |
How this compares
$1,374 in reported general payments places this provider in the 30th percentile of 88 urology providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Solifenacin Succinate | 13 | $855 |
| Tamsulosin Hcl | 31 | $681 |
| Finasteride | 17 | $276 |
Paid to pharmacies, not to this prescriber.
Other urology in Hot Springs
- Seth HollenbachHot Springs$57K
- Nathan LittlejohnHot Springs$18K
- Renee WarfordHot Springs$12K
- Charles WrightHot Springs$4K
- Donald MooneyLittle Rock$148K
- Timothy GoodsonLittle Rock$147K
- Ronald KuhnNorth Little Rock$138K
- Caleb BozemanLittle Rock$136K
- David CoussensLittle Rock$134K
- Timothy LangfordLittle Rock$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.